This CME/NCPD-approved podcast, featuring a discussion between two experts, will provide authoritative perspectives and evidence-based guidance on the following key clinical questions in the management of hemophilia A and B: What novel and emerging factor therapies provide significant advantages over existing factor therapies? What drives the need for alternatives to factor therapy? What do the data say about the efficacy and safety of novel and emerging gene therapies? Why is rebalancing hemostasis important in the treatment of hemophilia? What do the data say about the efficacy and safety of the hemostatic rebalancing agents that are in late-stage development? Will the advent of gene therapies, hemostatic rebalancing agents, and other novel forms of treatment spell the end of factor concentrates? What elements do you consider in choosing between treatment options for individual patients? If you have concerns about adherence for a particular patient, how does that impact your treatment selection and approach? What can health care providers do to improve adherence to treatment? How can pharmacokinetic-guided prophylaxis enhance treatment outcomes? To reinforce knowledge retention and expand the reach and distribution of the educational content to the broader health care provider audience, the activity has been made available as a CME/NCPD-approved episode of the i3 Health Podcast on Apple Podcasts, Spotify, and YouTube.
- Provider:i3 Health
- Activity Link: https://i3health.com/course-information/practice-changing-advances-in-the-management-of-hemophilia-podcast
- Start Date: 2024-06-21 05:00:00
- End Date: 2024-06-21 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.75 hours
AMA PRA Category 1 Credit™️: 0.75 hours
Nursing: 0.75 hours - MOC Credit Details: ABIM - 0.75 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Sanofi S.A. - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology, Medical Oncology